Huiyun biology keng bu keng

Painting clouds does not pit creatures. The detection sensitivity of Huayun Biological Biliary Obstruction Screening Kit was 100%, and the specificity was 98.8%. This product has applied for international PCT patent, and the national third-class medical device registration certificate is being examined and approved. And formally signed a strategic cooperation agreement with Bosheng Bio, the leading overall solution provider of birth defect prevention and control in China. Huayun biological mass spectrometry detection platform was founded on 20 18, based on the research experience of metabonomics and translational medicine in recent 20 years and the construction of professional technical team. At present, a number of metabonomics scientific research achievements and industrial achievements have been transformed, including: chronic liver disease risk calculation software, liver fibrosis and cirrhosis risk calculation software, and a number of exclusive IVD detection kits and other products. Shenzhen Huayun Medical Laboratory, a wholly-owned subsidiary of Huayun Bio, has obtained the practice license of medical institutions and can provide a full set of professional clinical metabonomics detection services.